Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Progressive neurodegenerative disorders presenting with behavioral or language abnormalities
FTLD with motor neuron disease (FTLD-MND)—cognitive dysfunction with the following:
Clinical features of motor neuron disease or
Ubiquitin-immunoreactive, tau-negative inclusion bodies within motor neurons histologically (with or without symptoms of MND)
FTLD with ubiquitin-only-immunoreactive neuronal changes (FTLD-U)—cognitive dysfunction with the following:
Ubiquitin-immunoreactive, tau-negative inclusions
No clinical/histologic evidence of MND
No gender predilection
Age range: 39 to 77 years old (FTLD-MND) and 53 to 83 years old (FTLD-U)
FTLD-U and FTLD-MND cases have abnormal transactive response DNA-binding protein-43 (TDP-43); encoded by the TARDBP gene on chromosome 1
TDP-43 is hyperphosphorylated, abnormally folded, and bound to ubiquitin forming neuronal and glial intranuclear and intracytoplasmic inclusions
A subset of patients with FTLD-U and FTLD-MND have mutations of the C9ORF72 gene on chromosome 9p
15% to 25% of FTLD-U cases have mutation in progranulin ( PGRN ) gene
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here